Ara
Toplam kayıt 75, listelenen: 11-20
Definitive Chemoradiotherapy in Elderly Cervical Cancer Patients: A Multiinstitutional Analysis
(2017)
Objective The aim of the study was to investigate the prognostic factors for survival and treatment-related toxicities in older (65 years) cervical cancer patients treated with definitive chemoradiotherapy. In addition, ...
Clinical characteristics of relapsed ovarian cancer patients with striking response to the bevacizumab at first relapse
(2020)
Background: Ovarian cancer is fifth leading cause of the cancer related death in women. Platin based doublet regimen plus bevacizumab is standard treatment in relapse. The primary aim of this study is to define clinicopathological ...
Treatment Outcomes of Breast Cancer Liver Metastasis Treated with Stereotactic Body Radiotherapy
(2018)
Background: To assess the outcomes of breast cancer liver metastasis (BCLM) treated with stereotactic body radiotherapy (SBRT) and systemic treatment.
Materials and methods: Patients with oligometastasis at the time of ...
Prognostic Value of Metabolic Response Measured by FDG-PET-CT in Patients with Breast Cancer Liver Metastasis Treated with Stereotactic Body Radiotherapy
(2018)
OBJECTIVE
To investigate the impact of metabolic response measured by 18-fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET-CT) in patients with breast cancer liver metastasis (BCLM) treated ...
Prognostic factors of endometrial cancer in elderly patient group and their effects on survival
(2021)
OBJECTIVE: The objective of the study was to investigate the prognostic factors of the elderly group and their effects on survival by examining the histopathological features, surgical treatment protocols, and treatment ...
Long-term outcomes of cervical cancer patients with complete metabolic response after definitive chemoradiotherapy
(2021)
Objective: We investigated the importance of metabolic parameters measured with F-18-fluorodeoxyglucose positron-emission tomography integrated with computed tomography (FDG-PET/CT) for predicting progression-free survival ...